Application for Arts-Based Social Prescribing
Member Engagement Application for Personalized Arts-based Social Prescriptions
The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care.
The main question it aims to answer is:
Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness.
Participants will:
Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment.
Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months).
If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Peter Research & Evaluation Manager
- Numéro de téléphone: 845-807-8005
- E-mail: peter@socialrx.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
Participants must meet the following criteria:
- Aged 15-18 years enrolled in Medicaid managed care
- Positive screen for depression and/or anxiety (e.g., PHQ-2 or GAD-2 ≥ 3)
- Currently own and easily operate a smartphone
- Have a valid e-mail address checked regularly
- English fluency, and
- Have a stable treatment regimen for at least 30 days prior to baseline with no planned treatment changes.
Exclusion Criteria:
Participants will be excluded if they:
- Endorse current suicidal ideation at study screening, defined as a response ≥ 1 ("several days") on Item 9 of the PHQ-9A
- Initiate a new treatment regimen or plan on initiating a new treatment regimen (i.e., medication, psychotherapy, or mind-body interventions) at the time of enrollment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Art Pharmacy program delivered through the SocialRx App
A personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app, SocialRx App
|
A personalized arts-based social prescribing program
|
|
Comparateur actif: Stable treatment
Existing, stable treatment regimen without major changes
|
Stable treatment (no change to existing care) through Medicaid managed care
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Anxiety - Generalized Anxiety Disorder-7 (GAD-7)
Délai: At baseline, and 3-, 6-, 9- and 12-month follow up.
|
The GAD-7 is a 7-item self-report measure of anxiety symptoms.
Scores range from 0 to 21, with higher scores indicating greater anxiety severity.
|
At baseline, and 3-, 6-, 9- and 12-month follow up.
|
|
Depression - Patient Health Questionnaire-9 Adolescent Version (PHQ-9A)
Délai: At baseline, and 3-, 6-, 9- and 12-month follow up.
|
The PHQ-9A is a 9-item self-report measure of depressive symptoms in adolescents.
Scores range from 0 to 27, with higher scores indicating greater depression severity.
|
At baseline, and 3-, 6-, 9- and 12-month follow up.
|
|
Loneliness - UCLA Loneliness Scale
Délai: At baseline, and 3-, 6-, 9-, and 12-month follow up
|
The UCLA Loneliness Scale assesses subjective feelings of loneliness and social isolation.
Scores range from 20 - 80, with higher scores indicating a higher degree of loneliness.
|
At baseline, and 3-, 6-, 9-, and 12-month follow up
|
|
Social Connectedness - Social Connectedness Scale-Revised (SCS-R)
Délai: At baseline, and 3-, 6-, 9-, and 12-month follow up
|
The SCS-R measures feelings of interpersonal closeness and connectedness.
Scores range from 20 to 120, with higher scores indicating greater social connectedness.
|
At baseline, and 3-, 6-, 9-, and 12-month follow up
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Treatment Utilization - Treatment and Arts/Cultural Engagement Utilization Questionnaire
Délai: At baseline, and 3-, 6-, 9-, and 12-month follow up
|
A study-developed questionnaire assessing participant engagement with behavioral health treatment and arts/cultural activities.
Higher scores/frequencies indicate greater utilization and engagement.
|
At baseline, and 3-, 6-, 9-, and 12-month follow up
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Dawn McDaniel, PhD, SocialRx Inc
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 26.0599
- R44AT013552 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .